|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction显示文摘ObjectiveDoppler 导出僧帽形的山峰到减速时间比率(E/DT ) 的早心脏舒张的充满速度为在一般人口预言预后作为参数被建议了。这研究有希望地在就医的病人在临床的、常规 echocardiographic 和 mitral-Doppler 变量上调查 E/DT 的增长的预示的值因为患心脏代偿失调的心失败(HF ).MethodsWe 分析了 95 个 HF 病人(吝啬的年龄 64.8 ±12.2 年) 从 2010 年 1 月在我们的机构就医了到 2012 年 3 月。主要端点是心脏的死亡或住院,无论哪个首先发生了。考克斯回归分析被执行识别 outcomes.ResultsDuring 后续的重要预言者(中部 37.7 个月) 13 个病人死了, 44 为一个心脏的事件被就医。在 univariable 分析,纽约心协会(NYHA ) 功能的班, furosemide 剂量,侧面的有三尖的环形的飞机收缩旅行,减速时间和 E/DT 结果是预兆的。在 multivariable 分析, E/DT 是预后的唯一的预言者(危险比率 = 1.02, P = 0.018 ) ,把增长预示的信息给临床并且另外的 echocardio 图形的措施(从 15.4 ~ 25.2 的全球 chi 平方;P = 0.032 ).ConclusionsE/DT 在 HF 病人给独立、增长的预示的信息。 | Flora Pirozzi AntoneUa Paglia Laura Sasso Pasquale Abete Angelo Carlomagno Carlo G Tocchetti Domenico Bonaduce Mario Petretta | 2015 | Journal of Geriatric Cardiology2015,12,4: | 2 |
| 2 | Calciumchannelblockers and cardiovascular outcomes:a meta-analysisofl75,634 patients显示文摘 | Costanzo P Perrone-Filardi P Petretta M | 2009 | J Hypertens2009,27,6: | 1 |
| 3 | Influence of Reverisible Segemental Left Ventricular Disfunction of Heart Rate Variability in Patients with One-vessel Coronary Heart Disease显示文摘 | Petretta M Piscione F | 1994 | J Am Coll Cardiol1994,24,2: | 1 |
| 4 | Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction显示文摘 | Bonaduce D Marciano F Petretta M | 1994 | Circulation1994,90,: | 1 |
| 5 | Successful coronary revascular- ization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging显示文摘 | Cuoeolo A Petretta M Nicolai E | 1998 | Eur J Nucl Med1998,25,1: | 1 |
| 6 | Heart rate variability as a measure of autonomic nervous system function in anorexia nervosa显示文摘 | Bonaduce D Scalfi L | 1997 | Clin Cardiol1997,20,3: | 1 |
| 7 | Imaging techniques for as- sessment of coronary flow reserve显示文摘 | Petretta M Acampa W Zampella E | 2011 | Monaldi Arch Chest Dis2011,76,4: | 1 |
| 8 | Impact of gender in primary prevention of coronary heart disease with statin therapy : a meta-analysis 显示文摘 | Petretta M Costanzo P Perrone-Filardi P | 2010 | Int J Cardiol2010,138,: | 1 |
| 9 | Calcium channel blockers and cardiovascular outcomes:a meta-analysis of 175,634patients显示文摘 | Costanzo P Perrone-Filardi P Petretta M | 2009 | J Hypertens2009,27,6: | 1 |
| 10 | Migraine and movement disorders显示文摘 | d'Onofrio F Barbanti P Petretta V | 2012 | Neurol Sci2012,33,1: | 1 |
| 11 | Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction显示文摘 | BONADUCE D MARCIANO F PETRETTA M | 1994 | Circulation1994,90,: | 1 |
| 12 | Intensive training and cardiac autonomic control in high level athletes显示文摘 | Bonaduce D Petretta M Cavallaro V Apicella C Ianniciello A Romano M Breglio R Marciano F | 1998 | Med Sci Sports Exerc1998,30,5: | 1 |
| 13 | Calcium channel blockers and cardiovascular outcomes:a meta-analysis of 175,634 patients显示文摘 | Costanzo P Perrone-Filardi P Petretta M | 2009 | J Hypertens2009,27,: | 1 |
| 14 | Gated spect myocardial perIusion imaging:the further improvements of aa excellent tool显示文摘 | CUOCOLO A PETRETTA M ACAMPA W etal | 2010 | Q J Nucl Med Mol Imag2010,54,2: | 1 |
| 15 | Calcium channel blockers and cardiovascular outcomes: a recta-analysis of 175,634 patients显示文摘 | Costanzo P Perrone-Filardi P Petretta M | 2009 | J Hypertens2009,27,6: | 1 |
| 16 | Influence of reversible segmental left vent ricular dysfunction on heart period variability in patients with one-vessel coronary artery disease显示文摘 | Bonaduce D Petretta M Piscione F | 1994 | J Am Coll Cardiol1994,24,2: | 1 |
| 17 | Calcium channel blockers and cardiovascular outcomes : a meta-analysis of 175,634 patients 显示文摘 | Costanzo P Perrone-Filardi P Petretta M | 2009 | J Hyper- tens2009,27,: | 1 |
| 18 | Independent and incremental prognostic value heart rate variability in patients with chronic heart failure 显示文摘 | Bonaduce D Petretta M Marciano F | 1999 | Am Heart J1999,138,2: | 1 |
| 19 | Role of nuclear cardiology for guiding device therapy in patients with heart failure显示文摘Heart failure is a dynamic condition with high morbidity and mortality and its prognosis should be reassessed frequently, particularly in patients for whom critical treatment decisions may depend on the results of prognostication. In patients with heart failure, nuclear cardiology techniques are useful to establish the etiology and the severity of the disease, while fewer studies have explored the potential capability of nuclear cardiology to guide cardiac resynchronization therapy(CRT) and to select patients for implantable cardioverter defibrillators(ICD). Left ventricular synchrony may be assessed by radionuclide angiography or gated singlephoton emission computed tomography myocardial perfusion scintigraphy. These modalities have shown promise as predictors of CRT outcome using phase analysis. Combined assessment of myocardial viability and left ventricular dyssynchrony is feasible using positron emission tomography and could improve conventional response prediction criteria for CRT. Preliminary data also exists on integrated positron emission tomography/computed tomography approach for assessing myocardial viability, identifying the location of biventricular pacemaker leads, and obtaining left ventricular functional data, including contractile phase analysis. Finally, cardiac imaging with autonomic radiotracers may be useful in predicting CRT response and for identifying patients at risk for sudden cardiac death, therefore potentially offering a way to select patients for both CRT and ICD therapy. Prospective trials where imaging is combined with image-test driven therapy are needed to better define the role of nuclear cardiology for guiding device therapy in patients with heart failure. | Mario Petretta Andrea Petretta Teresa Pellegrino Carmela Nappi Valeria Cantoni Alberto Cuocolo | 2014 | World Journal of Meta-Analysis2014,2,1: | 1 |
| 20 | Calcium channel blockers and cardiovascular outcomes:a meta-analysis of 175 634 patients显示文摘 | Costanzo P Perrone-Filardi P Petretta M | 2009 | J Hypertens2009,27,: | 1 |